ARTICLE | Clinical News
NPM1 assay: Pilot trial data
October 18, 2010 7:00 AM UTC
Asuragen Inc., Austin, Texas Product: NPM1 assay ( Signature NPM1 Mutations assay) Business: Diagnostic Molecular target: Nucleophosmin (NPM1) (B23) Description: RNA-based assay combining multiplex ...